These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2105111)

  • 1. Recombinant interferon-alpha, but not interferon-gamma is effective therapy for essential thrombocythemia.
    Abegg-Werter MJ; Raemaekers JM; de Pauw BE; Haanen C
    Blut; 1990 Jan; 60(1):37-40. PubMed ID: 2105111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosis.
    Talpaz M; Kurzrock R; Kantarjian H; O'Brien S; Gutterman JU
    Am J Med; 1989 May; 86(5):554-8. PubMed ID: 2712063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon in essential thrombocythaemia.
    Gisslinger H; Chott A; Scheithauer W; Gilly B; Linkesch W; Ludwig H
    Br J Haematol; 1991 Oct; 79 Suppl 1():42-7. PubMed ID: 1931708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of human recombinant interferon-alpha-2C in essential thrombocythaemia.
    Velu T; Delwiche F; Gangji D; Monsieur R; Flament J; Stryckmans P; Wybran J; Bellens R
    Oncology; 1985; 42 Suppl 1():10-4. PubMed ID: 4080296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient normal platelet counts and decreased requirement for interferon during pregnancy in essential thrombocythaemia.
    Shpilberg O; Shimon I; Sofer O; Dolitski M; Ben-Bassat I
    Br J Haematol; 1996 Feb; 92(2):491-3. PubMed ID: 8603023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon alpha-2b in the long-term treatment of essential thrombocythemia.
    Sacchi S; Tabilio A; Leoni P; Riccardi A; Vecchi A; Messora C; Falzetti F; Rupoli S; Ucci G; Martelli MF
    Ann Hematol; 1991 Oct; 63(4):206-9. PubMed ID: 1932299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseases.
    Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Scheithauer W; Kuzmits R; Linkesch W; Gisslinger H; Sinzinger H; Fritz E
    Oncology; 1985; 42 Suppl 1():19-25. PubMed ID: 4080297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-interferon therapy for essential thrombocythaemia.
    Giles FJ; Singer CR; Gray AG; Yong KL; Brozovic M; Davies SC; Grant IR; Hoffbrand AV; Machin SJ; Mehta AB
    Lancet; 1988 Jul; 2(8602):70-2. PubMed ID: 2898699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
    Kuzmits R; Scheithauer W; Ludwig H; Flener R
    Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].
    Niederle N; Doberauer C; Kloke O; Höffken K; Schmidt CG
    Klin Wochenschr; 1987 Jul; 65(14):706-12. PubMed ID: 3114551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained complete hematological remission in essential thrombocythemia after discontinuation of long-term alpha-IFN treatment.
    Sacchi S; Tabilio A; Leoni P; Riccardi A; Vecchi A; Messora C; Bensi L; Falzetti F; Rupoli S; Ucci G
    Ann Hematol; 1993 May; 66(5):245-6. PubMed ID: 8507719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated interferon for the treatment of high risk essential thrombocythemia: results of a phase II study.
    Langer C; Lengfelder E; Thiele J; Kvasnicka HM; Pahl HL; Beneke H; Schauer S; Gisslinger H; Griesshammer M
    Haematologica; 2005 Oct; 90(10):1333-8. PubMed ID: 16219569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission may continue after termination of rIFN alpha-2b treatment for essential thrombocythemia.
    Kasparu H; Bernhart M; Krieger O; Lutz D
    Eur J Haematol; 1992 Jan; 48(1):33-6. PubMed ID: 1730277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of essential thrombocythaemia by alpha 2a interferon.
    Bellucci S; Harousseau JL; Brice P; Tobelem G
    Lancet; 1988 Oct; 2(8617):960-1. PubMed ID: 2902403
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical study with recombinant interferon gamma versus interferon alpha-2c in patients with condylomata acuminata.
    Reichel RP; Fitz R; Neumann R; Pohl-Markl H; Pichler E; Hoffer Z; Budiman R
    Int J STD AIDS; 1992; 3(5):350-4. PubMed ID: 1391062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential thrombocythemia--clinical features, therapy and follow-up of 12 cases.
    Lopes E; Ribeiro MM; Silva MJ; Gandra M; Principe F; Granato C
    Leukemia; 1992; 6 Suppl 3():138S-140S. PubMed ID: 1602810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia.
    Kloke O; Becher R; Niederle N
    Blut; 1987 Nov; 55(5):453-8. PubMed ID: 3118992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [alpha-Interferon in the treatment of essential thrombocythemia].
    Hashizume M; Iki S; Yagisawa M; Ohbayashi Y; Sato H; Urabe A
    Rinsho Ketsueki; 1992 Feb; 33(2):232-7. PubMed ID: 1635175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long-term clinical trial of interferon alpha-therapy in essential thrombocythemia.
    Middelhoff G; Boll I
    Ann Hematol; 1992 May; 64(5):207-9. PubMed ID: 1623054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia.
    Jootar S
    Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.